NovaBridge Biosciences

NBP
CUSIP 44975P103 Nasdaq ADR
Reported in filings as: NOVABRIDGE BIOSCIENCES
Option CUSIPs: 44975P903 44975P953

Institutional ownership · Q3 2026

Institutional holders 47 -2 (-4.1%) vs Q2 2026
Reported value $31.1M -35.4% vs Q2 2026
Shares held 22.8M -1.9M shares
Quarter Q3 2026 Period ended Sep 30, 2026

47 institutional managers reported holding 22,775,245 shares worth $31,086,637 on Form 13F for Q3 2026, against 49 in Q2 2026. Share positions on CUSIP 44975P103 only; option legs and principal-amount lines are not counted.

Top 25 institutional holders · Q3 2026

Largest Q3 2026 Form 13F holders of CUSIP 44975P103 by reported value
# Manager Shares Value % of portfolio Change Position page
1 HHLR ADVISORS LTD 5,980,568 $8.2M 0.53% — Position
2 MORGAN STANLEY 3,471,552 $4.7M < 0.01% -181.7K Position
3 AIHC Capital Management Ltd 2,878,033 $3.9M 3.61% — Position
4 CITADEL ADVISORS LLC 1,381,516 $1.9M < 0.01% +758.7K Position
5 Candriam S C A 1,132,563 $1.6M < 0.01% — Position
6 ADAGE CAPITAL PARTNERS GP L L C 1,000,000 $1.4M < 0.01% — Position
7 TWO SIGMA INVESTMENTS LP 874,250 $1.2M < 0.01% +22.9K Position
8 BlackRock Inc 749,282 $1.0M < 0.01% +63.1K Position
9 MARSHALL WACE LLP 727,345 $989.2K < 0.01% -504.6K Position
10 UBS Group AG 689,762 $941.5K < 0.01% +388.0K Position
11 Exome Asset Management LLC 576,960 $787.6K 0.51% — Position
12 DIADEMA PARTNERS LP 500,000 $682.5K 0.09% New Position
13 RENAISSANCE TECHNOLOGIES LLC 485,191 $662.3K < 0.01% -273.0K Position
14 Woodline Partners LP 350,000 $477.8K < 0.01% — Position
15 Fiera Capital Corp 315,681 $430.9K < 0.01% — Position
16 STATE STREET CORPORATION 312,640 $426.8K < 0.01% -47.7K Position
17 XTX Topco Ltd 159,492 $217.7K < 0.01% New Position
18 ALPS ADVISORS INC 150,167 $205.0K < 0.01% +33.1K Position
19 JANE STREET GROUP LLC 145,666 $198.8K < 0.01% +127.3K Position
20 Persistent Asset Partners Ltd 126,943 $173.3K 0.05% New Position
21 The Goldman Sachs Group Inc 124,643 $170.1K < 0.01% -36.7K Position
22 Quadrature Capital Ltd 109,026 $148.8K < 0.01% New Position
23 ACADIAN ASSET MANAGEMENT LLC 98,344 $131.0K < 0.01% New Position
24 Invesco Ltd 73,731 $100.6K < 0.01% +10.8K Position
25 HRT FINANCIAL LP 59,010 $80.0K < 0.01% New Position

Values as reported on each manager's Q3 2026 Form 13F. Change is in shares against the manager's prior-quarter filing.

13F holders by quarter

Form 13F holders of CUSIP 44975P103 by quarter
Quarter Holders Shares Value
Q3 2026 47 -2 22.8M $31.1M
Q2 2026 49 +1 24.7M $48.1M
Q1 2026 48 -8 29.3M $72.1M
Q4 2025 56 +14 33.2M $132.1M
Q3 2025 42 +10 29.7M $112.3M
Q2 2025 32 +3 9.4M $22.7M
Q1 2025 29 +1 9.0M $7.4M
Q4 2024 28 11.9M $10.1M
Q3 2024 28 -10 14.2M $17.6M
Q2 2024 38 -1 15.1M $25.3M
Q1 2024 39 -5 12.2M $22.7M
Q4 2023 44 -3 12.3M $23.5M
Q3 2023 47 -1 19.4M $33.4M
Q2 2023 48 -5 18.7M $55.9M
Q1 2023 53 -15 20.7M $71.6M
Q4 2022 68 -6 24.9M $103.9M
Q3 2022 74 -20 30.8M $123.3M
Q2 2022 94 -21 38.2M $430.9M
Q1 2022 115 -12 40.3M $657.1M
Q4 2021 127 38.9M $1.8B

Q4 2021–Q3 2026, as reported on Form 13F. Earlier quarters are in the ownership explorer below.

Fund holders · N-PORT

14 funds
Largest fund holders of CUSIP 44975P103 reported on Form N-PORT
Fund Value % of fund As of
iShares Biotechnology ETF IBB $1.2M 0.01% Jun 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPEM $580.8K < 0.01% Jun 2026
ALPS Medical Breakthroughs ETF SBIO $259.9K 0.11% Aug 2026
Invesco NASDAQ Future Gen 200 ETF QQQS $110.5K 0.49% Aug 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF EWX $94.2K 0.01% Jun 2026
Fidelity Nasdaq Composite Index Fund $80.3K < 0.01% Aug 2026
World ex U.S. Core Equity Portfolio $42.1K < 0.01% Jul 2026
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO $32.1K < 0.01% Jul 2026
State Street(R) SPDR(R) S&P(R) China ETF GXC $27.7K < 0.01% Jun 2026
Emerging Markets Social Core Equity Portfolio $24.2K < 0.01% Jul 2026

14 funds reported holding $2,449,779 in total on their latest public Form N-PORT reports, the most recent dated August 2026.

5%+ holders · 13D/G

3 filers
Schedule 13D and 13G filers reporting a stake in CUSIP 44975P103
Filer % of class Filed
HHLR ADVISORS LTD 13D 4.9% 2026-11-06
CBC Investment I-Mab Limited 13D 11.5% 2026-02-03
Everest Medicines Limited 13D 16.1% 2025-08-05

Latest Schedule 13D or 13G from each filer naming this CUSIP; stakes a filer has reported closed are left out.

Insiders · Form 4

Net insider transactions, 12 months +$423K 1 filing with purchases ($577K), 7 filings with sales ($154K)
Latest filings
All NovaBridge Biosciences insider filings

Ownership explorer

Loading ownership explorer…

Security Details

CUSIP 44975P103
FIGI BBG00QQ8DG97
Symbol NBP
Type Adr
Class SPONSORED ADS as filed on 13F
Exchange Nasdaq
Company NovaBridge Biosciences

Identifier History

Type Value From To
FIGI BBG00QQ8DG97 2026-02-07 Current
CUSIP 44975P103 2020-03-31 Current

Listing History

Symbol Exchange From To
NBP Nasdaq 2025-10-31 Current
IMAB Nasdaq 2020-05-04 2026-07-18